Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing
Reexamination Certificate
2005-02-14
2010-11-02
Jones, D L (Department: 1618)
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
C424S001110, C424S001650, C424S001690, C548S300100, C548S215000, C548S146000
Reexamination Certificate
active
07824661
ABSTRACT:
One aspect of the invention relates to complexes of a radionuclide with various heteroaryl ligands, e.g., imidazolyl and pyridyl ligands, and their use in radiopharmaceuticals for a variety of clinical diagnostic and therapeutic applications. Another aspect of the invention relates to imidazolyl and pyridyl ligands that form a portion of the aforementioned complexes. Methods for the preparation of the radionuclide complexes are also described. Another aspect of the invention relates to imidazolyl and pyridyl ligands based on derivatized lysine, alanine and bis-amino acids for conjugation to small peptides by solid phase synthetic methods. Additionally, the invention relates to methods for imaging regions of a mammal using the complexes of the invention.
REFERENCES:
patent: 7381399 (2008-06-01), Babich et al.
patent: 2002/0061599 (2002-05-01), Elling et al.
patent: 2003/0235843 (2003-12-01), Babich et al.
patent: 2006/0093552 (2006-05-01), Babich et al.
patent: 2008/0025915 (2008-01-01), Babich et al.
patent: 2009/0023787 (2009-01-01), Babich et al.
patent: 2009/0148382 (2009-06-01), Babich et al.
patent: 1021526 (1966-03-01), None
patent: 10-504521 (1998-05-01), None
patent: WO 95/29924 (1995-11-01), None
patent: WO 98/50393 (1998-11-01), None
patent: WO 01/91807 (2001-12-01), None
Gomez-Romero et al, Journal of the American Chemical Society (1988), vol. 110, No. 6, pp. 1988-1990.
Alberto et al., “A Novel Organometallic Aqua Complex of Technetium for the Labeling of Biomolecules: Synthesis of [99mTc(OH2)3(CO)3]+from [99mTcO4]−in Aqueous Solution and its Reaction with a Bifunctional Ligand”, J. Am. Chem. Soc. 120:7987-7988 (1998).
Alberto et al., “Application of Technetium and Rhenium Carbonyl Chemistry to Nuclear Medicine. Preparation of [NEt4]2[TcCl3] from [NBu4][TcO4] and Structure of [NEt4][Tc2(μ-Cl)3(CO)6]; Structures of the model complexes [NEt4][Re2(μ-OEt)2(μ-OAc)(CO)6] and [ReBr({-CH2S(CH2)2Cl}2(CO)3]”, Transition Met. Chem., 22: 597-601 (1997).
Davison et al., “A new Class of Oxotechnetium (5+) Chelate Complexes Containing a TcON2S Core”, Inorg. Chem. 20(6): 1629-1632 (1981).
Kung et al., New Tc-99 Complexes Based on N2S2Ligands, J. Nucl. Med., 28(5): 1051 (Abstract No. 719) (1986).
Hom and Katzenellenbogen, “Technetium-99m-Labeled Receptor-Specific Small-Molecule Radiopharmaceuticals: Recent Developments and Encouraging Results”, Nucl. Med. Biol., 24: 485-498 (1997).
Kung et al., “Synthesis and Biodistribution of Neutral Lipid-Soluble Tc-99m Complexes that Cross the Blood-Brain Barrier”, J. Nucl. Med., 25: 326-332 (1984).
Kung et al.; “Synthesis of New Bis(aminoethanethiol) (BAT) Derivatives: Possible Ligands for99mTc Brain Imaging Agents”, J. Med.Chem., 28: 1280-1284 (1985).
Maresca et al., “Synthesis and Characterization of a Binuclear Rhenium Nitropyrazole Complex [Re2O3Cl2(PPh3)2(C3H2N3O2)2]”, Inorganica Chimica Acta, 260: 83-88 (1997).
Maresca et al., “Cationic complexes of the ‘3+1’ oxorhenium-thiolate family”, Ingoranica Chimica Acta, 297: 98-105 (2000).
Nicholson et al., “The Synthesis and Characterization of [MC13(N=NC5H4NH) (HN=NC5H4N) from [MO4]−(where M = Re, Tc) Organodiazenido, Organdiazene-chelate Complexes. The X-ray Structure of [ReC13(N=NC5H4NH) (HN=NC5H4N)],” Ingoranica Chimica Acta, 252: 421-426 (1996).
Reedjik, J.. “Medicinal Applications of Heavy-Metal Compounds”, Curr. Opin. Chem. Biol., 3: 236-240 (1999).
Rose et al., “Synthesis and Characterization of Organhydrazino Complexes of Technetium, Rhenium, and Molybdenum with the {M(η1-HxNNR) (η2-HyNNR)}Core and Their Relationship to Radiolabeled Organohydrazine-Derivatized Chemotactic Peptides with Diagnostic Applications”, Inorg. Chem., 37: 2701-2716 (1998).
Salamain et al., “Labeling of Proteins by Organometallic Complexes of Rhenium(I). Synthesis and Biological Activity of the Conjugates”, Bioconjugate Chem., 4: 425-433 (1993).
Van Staveren et al., “Spectroscopic Properties, Electrochemistry, and Reactivity of Mo0, MoI, MoIIComplexes with the [Mo(bpa)(CO)3] Unit[bpa = bis(2-picolyl)amine] and their Application for the Labelling of Peptides”, Eur.. J. Inorg. Chem., pp. 1518-1529 (2002).
Banerjee, S.R., et al., Bifunctional Single Amino Acid Chelates for Labeling of Biomolecules with the {Tc(CO)3}+and {Re(CO)3}+Cores. Crystal and Molecular Structures of [ReBr(CO)3(H2NCH2C5H4N], [Re(CO)3{(C5H4NCH2)2NH}]Br, [Re(CO)3{C5H4NCH2)2NCH2CO2H}BR,]Re(CO)3{X(Y)NCH2CO2CH2CH3}]Br, (X = Y= 2-pyridylmethyl; X = 2-pyridylmethyl, Y = 2-(1-methylimidazolyl)methyl; X = Y = 2-(1-methylimidazolyl)methyl), [ReBr(CO)3{(C5H4NCH2)NH(CH2C4H3S)}], and [Re(CO)3{(C5H4NCH2) N(CH2C4H3S(CH2CO2)}] Inorg. Chem., 41: 6417-6425 (2002).
International Search Report for PCT/US05/04407 mailed Jun. 29, 2005.
International Search Report for PCT/US05/04448 mailed Jul. 6, 2005.
Okuno et al.; Oxidation of Cyclohexane with Hydrogen Peroxide Catalysed by Copper (II) Complexes Containing N, N-bis(2-pyridylmethyl)-β-alanineamide Ligands; Polyhedron, 1997, vol. 16, No. 21, pp. 3765-3774.
European Search Report (EP 03 71 1512); Date of Completion May 15, 2006; 3 pages.
Nelson, S.M. et al.; “Strong-field nonconjugated polyamine ligand: low-spin iron (II) and high-spin nickel (II) complexes;” Journal of the Chemical Society (A); 1968; 3 pages.
Cox, D.D. et al.; “Catecholate LMCT Bands as Probes for the Active Sites of Nonheme Iron Oxygenases;” Journal of the American Chemical Society; 1988; pp. 2026-2032.
Abufarag, Ahmed et al.; “Zinc Complexes of the Ligand Dipicolylglycine;” Inorganic Chemistry; 1995; pp. 2207-2216.
Schibli, Roger et al.; “Influence of the Denticity of Ligand Systems on the in Vitro and in Vivo Behavior of 99mTC(I)—Tricarbonyl Complexes: A Hint for the Future Functionalization of Biomolecules;” Bioconjugate Chemistry; pp. 345-351.
La Bella Roberto et al.; “In vitro and in vivo evaluation of a99mTc(I)-labeled bombesin analogue for imaging of gastrin releasing peptide receptor-positive tumors;” Nuclear Medicine and Biology; 2002; pp. 553-560.
Banerjee at al.; “{Re°1CI3} Core Complexes with Bifunctional Single Amino Acid Chelates”, Inorganic Chemistry 41(22): 5795-5802, 2002.
Hauser et al., “Substitutions at the α- or γ-positions in pyridyl ring systems by basic reagents,” Journal of Organic Chemistry, 1949, vol. 14, pp. 310-321.
International Search Report, PCT/US03/07328 Date of Completion Nov. 19, 2003.
Murali et al., “Direct Reductive Alkylation of Amino Acids: Synthesis of Bifunctional Chelates for Nuclear Imaging” Synthesis, (2004) No. 11, 1759-1766.
Supplementary Partial European Search Report (EP 05713382) Date of Completion Jun. 10, 2009, 4 pgs.
Supplementary Partial European Search Report (EP 05722979) Date of Completion Jun. 9, 2009, 4 pgs.
Xu et al., “Synthesis of tris((3-isoquinolyl)methyl)amine and bis((2-pyridyl)methyl-(3-isoquinolyl)methylamine”, Inorganica Chimica Acta, vol. 256, 1997, pp. 125-128, Netherlands.
Amadei, et al., “Copper Monooxygenase Models: Hydroxylation Reactions resulting from Dioxygen Activation by Copper(I) Complexes,”Journal of the Chemical Society, Chemical Communications, 1992:1782-1784.
Kobayashi, et al., “Release of free nucleobases from oligomers by copper(II)—peroxide Adduct,”Polyhedron, 2000, 19:2639-2648.
Langer, et al., “99mTc-Labeled Neuropeptide Y Analogues as Potential Tumor Imaging Agents,”Bioconjugate Chemistry, 2001, 12(6):1028-1034.
Matouzenko, et al., “Polymorphism in Spin Transition Systems. Crystal Structure, Magnetic Properties, and Mössbauer Spectroscopy of Three Polymorphic Modifications of [Fe(DPPA)(NCS)2] [DPPA=(3-Aminopropyl)bis(2-pyridylmethyl)amine],”Inorganic Chemistry, 1997, 36(25):5869-5879.
Wei, et al., “
Babich John W.
Kronauge, Jr. James F.
Maresca Kevin B.
Ewing James F.
Foley & Lardner LLP
Jones D L
Molecular Insight Pharmaceuticals, Inc.
Morency Michel
LandOfFree
Technetium- and rhenium-bis(heteroaryl) complexes, and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Technetium- and rhenium-bis(heteroaryl) complexes, and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Technetium- and rhenium-bis(heteroaryl) complexes, and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4214303